These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20560299)

  • 1. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2009; (958):1-242, back cover. PubMed ID: 20560299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
    World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selection and use of essential medicines.
    World Health Organ Tech Rep Ser; 2004; 920():1-127, back cover. PubMed ID: 15382605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).
    World Health Organ Tech Rep Ser; 2003; 914():i-vi, 1-126. PubMed ID: 12872478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2007; (946):1-162, back cover. PubMed ID: 18309920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2008; (950):backcover, vii-174. PubMed ID: 18754303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selection and use of essential medicines.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (965):i-xiv, 1-249. PubMed ID: 22891532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selection and use of essential medicines.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (985):i-xiv, 1-219, back cover. PubMed ID: 25080778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Selection and Use of Essential Medicines.
    World Health Organ Tech Rep Ser; 2015; (994):vii-xv, 1-546. PubMed ID: 27183787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of essential drugs. Eighth report of the WHO Expert Committee (including the revised Model List of Essential Drugs).
    World Health Organ Tech Rep Ser; 1998; 882():1-77. PubMed ID: 9922706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of essential drugs.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2000; 895():1-61. PubMed ID: 11286007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of essential drugs. Seventh report of the WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1997; 867():1-74. PubMed ID: 9299932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global aspects of drug development.
    Hoppu K; Hogerzeil HV
    Handb Exp Pharmacol; 2011; 205():353-72. PubMed ID: 21882121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?
    Logez SM; Hutin YJ; Holloway K; Gray R; Hogerzeil HV
    J Clin Pharmacol; 2004 Oct; 44(10):1106-13. PubMed ID: 15342611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World Health Organization program for the selection and use of essential medicines.
    Reidenberg MM
    Clin Pharmacol Ther; 2007 Apr; 81(4):603-6. PubMed ID: 17314928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential medicines for children.
    Hoppu K; Sri Ranganathan S
    Arch Dis Child; 2015 Feb; 100 Suppl 1():S38-42. PubMed ID: 25613966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the selection and use of essential medicines decrease inappropriate drug use?
    Reidenberg MM
    Clin Pharmacol Ther; 2009 Jun; 85(6):581-3. PubMed ID: 19451911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicines for cancers in children: The WHO model for selection of essential medicines.
    Robertson J; Magrini N; Barr R; Forte G; Ondari C
    Pediatr Blood Cancer; 2015 Oct; 62(10):1689-93. PubMed ID: 25929524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care.
    De Lima L; Krakauer EL; Lorenz K; Praill D; Macdonald N; Doyle D
    J Pain Symptom Manage; 2007 May; 33(5):521-6. PubMed ID: 17482041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.